Disciplined Investments, LLC Merck & Co., Inc. Transaction History

Disciplined Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$108.61 - $118.38 $1,303 - $1,420	-12 Reduced 1.81%	651 $75,000
Q1 2023 May 10, 2023	BUY	$102.94 - $114.86 $205 - $229	2 Added 0.3%	663 $70,000
Q4 2022 Feb 01, 2023	BUY	$87.44 - $112.11 $2,186 - $2,802	25 Added 3.93%	661 $73,000
Q3 2022 Nov 03, 2022	SELL	$84.53 - $94.96 $845 - $949	-10 Reduced 1.55%	636 $55,000
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $3,506 - $3,974	42 Added 6.95%	646 $59,000
Q1 2022 Apr 22, 2022	BUY	$73.51 - $82.4 $8,674 - $9,723	118 Added 24.28%	604 $50,000
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $1,757 - $1,944	-25 Reduced 4.89%	486 $38,000
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $13,349 - $14,814	-186 Reduced 26.69%	511 $42,000
Q4 2019 May 19, 2020	BUY	$77.58 - $87.54 $54,073 - $61,015	697 New	697 $63,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.